RFC
VNDA icon

Regions Financial Corp’s Vanda Pharmaceuticals VNDA Stock Holding History

Regions Financial Corp’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-13,934
Closed -$257K – 1694
2019
Q1 		$257K Buy
13,934
+3,095
+29% +$70.5K ﹤0.01% 715
2018
Q4 		$283K Buy
10,839
+1,230
+13% +$28.9K ﹤0.01% 656
2018
Q3 		$221K Buy
+9,609
New +$196K ﹤0.01% 805

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Regions Financial Corp's VNDA Position: Q2 2019 in Review

Regions Financial Corp sold out of Vanda Pharmaceuticals (VNDA) in Q2 2019, closing a stake of 13,934 shares — an estimated $257K sold.

Regions Financial Corp first reported a position in VNDA in Q3 2018 and held it in 3 quarters. The position peaked at $283K in Q4 2018. 164 funds tracked by Wall St. Rank hold VNDA as of Q2 2019.

  • Regions Financial Corp reported no remaining Vanda Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Regions Financial Corp sold 13,934 Vanda Pharmaceuticals shares in Q2 2019, an estimated $257K.
  • Regions Financial Corp first reported a position in Vanda Pharmaceuticals in Q3 2018 and held it in 3 quarters.
  • Regions Financial Corp's Vanda Pharmaceuticals position peaked at $283K in Q4 2018.
  • 164 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2019.

Based on Regions Financial Corp's 13F filing for Q2 2019, filed 19 Jul 2019.